Cardiac rehabilitation Circulatory System
Conditions
Interventions
Both groups follow a phase II cardiac rehabilitation program, they are monitored for 8 weeks
Intervention group supervision is by the telemedicine system
Control group have on-site supervision in the
psychological (anxiety control, relaxation)
education in cardiovascular risk factor control (medication, life habits)
return to work
sexual dysfunction
among others. The activities are prog
Sponsors
Hospital Universitario Ramón y Cajal
Instituto de Salud Carlos III
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients requiring phase II cardiac rehabilitation at the center due to ischemic heart disease (myocardial infarction, percutaneous or surgical revascularization); operated valvular heart disease or mixed heart surgery 2. Patients able to commit to the demands of the trial: the ability to understand, read and write the Spanish language, cognitive and manual ability to use the technological devices intended for the study 3. Patients who agree to participate in the study (sign oral or written informed consent) 4. Patients who have internet access at home
Exclusion criteria
Exclusion criteria: 1. Severe injury of three vessels not appropriate for revascularization 2. Angina/severe ischemia in provocation tests 3, Severe arrhythmia 4. Severe Left ventricle disfunction (EF 75 years 8. Any type of physical or mental disability that prevents the use of technological devices in the system and not have family support or otherwise
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Functional capacity in METs (metabolic equivalent), measured using the measured MET exercise test (ramp protocol), at baseline and the end of stage 1 (final phase II cardiac rehabilitation program) | — |
Secondary
| Measure | Time frame |
|---|---|
| Measured at baseline, week 8 and week 60: 1. Improvement in functional capacity in METs measurement by exercise testing (ramp protocol) at the end of the study (first year of Phase III). From exercise testing also: clinical (positive / negative) response; electrical response (positive /negative / not assessable); significant arrhythmias (atrial / ventricular); heart rate (basal/submaximal-60%/submaximal-80%/end/first minute of recovery). 2. Left ventricle Ejection fraction (echocardiogram). Cardiovascular risk factors: smoking (defined by smoking at enrollment); LDL cholesterol levels above 100 mg / dl; hypertension (defined as greater than 140 mm / Hg systolic or 90 mm / Hg in diastolic blood pressure 130 and 80 mm / Hg in diabetics or antihypertensive drugs); glucose, glycated Hb. 3. Psychological information: 3.1. Beck (depression) 3.2. STAI (anxiety) 3.3. Quality of life (EQ-5D-5L) 3.4. Individualized treatment (psychological / psychiatric). 4. Employment information: nature of work (white collar, blue collar, self employed, time of return to work in days) measured using self-report 5. Complications (angina, reinfarction, arrhythmias, heart failure, need for revascularization), mortality (cardiac or due to other causes) measured using patient records 6. Motivation by the program (self-reported Likert scale of 5 points between "high" and "very low"). 7. Self-reported satisfaction with the program at the end of the study (Likert scale of 5 points between "high" and "very low") 8. Usability of the system (System Usability Scale) | — |
Countries
Spain
Outcome results
None listed